Business · 28/02/2022Updated: 10/17/2026 · 1 min read
Fresenius Kabi USA, LLC, et al. Withdraw FDA Approval of Five Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of five abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications that the drug products were no longer in use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →